Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Prostate Cancer
Interventions
DRUG

Taxotere

Treatment will be administered on an outpatient basis. Treatment will be repeated every 28 days. Taxotere is administered on days 1, 8 and 15 (rate: 1 hour). Dose levels 1, 2 and 3 (mg/m2 i.v.) are 25, 25 and 30, respectively.

DRUG

Doxil

Treatment will be administered on an outpatient basis. Treatment will be repeated every 28 days. Doxil is administered on day 1 (rate: 1mg/min). Dose levels 1, 2 and 3 (mg/m2 i.v.) are 25, 30 and 30, respectively.

Trial Locations (1)

40202

James Graham Brown Cancer Center, Louisville

All Listed Sponsors
collaborator

James Graham Brown Cancer Center

OTHER

lead

University of Louisville

OTHER

NCT00456989 - Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer | Biotech Hunter | Biotech Hunter